ETFS Holding Allergan, Inc.

 
ETF Quotes for ETFS Holding Allergan, Inc. top ^
  • Holdings: Baker Hughes Inc , Allergan Inc , Time Warner Cable Inc , PetSmart Inc , Lorillard Inc ,
  • Morningstar Rating: 4 Stars
Sign-up for mna investment picks

 
Stock Quotes for Allergan, Inc. top ^
  • Industry: Drug Manufacturers - Specialty & Generic
  • Sector: Healthcare
  • Stock Style: Large Growth
  • Stock Type: Aggressive Growth
  • Morningstar Rating: 3 Stars
Sign-up for agn investment picks

 
News Articles for Allergan, Inc. top ^
2014/12/29
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1166853&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for AGN SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Involving Allergan, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of February 16, 2015 -- AGN investment picks
2014/12/23
Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of persons who sold the common stock of Allergan, Inc. (“Allergan” or the “Company”) (NYSE:AGN) between February 25, 2014 and April 21, 2014, concerning possible violations of federal securities laws.
Sign-up for SHAREHOLDER ALERT: Investors Who Sold Allergan, Inc. Common Stock Between February 25, 2014 and April 21, 2014 Are Encouraged to Contact Glancy Binkow & Goldberg LLP investment picks
2014/12/17
COTCHETT, PITRE & McCARTHY, LLP ( www.cpmlegal.com ) today announced that a class action has been commenced in the United States District Court for the Central District of California on behalf of persons who sold Allergan, Inc. (NYSE: AGN) common stock between February 25, 2014 and April 21, 2014 (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court no later than 60 days from December 17, 2014.
Sign-up for COTCHETT, PITRE & McCARTHY, LLP Files Class Action Lawsuit on Behalf of Persons Who Sold Allergan Stock Between February 25, 2014 and April 21, 2014 investment picks
2014/12/17
SAN DIEGO, Dec.
Sign-up for Deadline in Lawsuit for Certain Sellers of Allergan, Inc. (AGN) Shares Announced by Shareholders Foundation investment picks
2014/12/16
- Brent Saunders to Lead as CEO and President - - Leadership Reflects Exceptional Combined Expertise of Actavis and Allergan - - Commercial Leadership Operating Model to Optimize Allergan Expertise and Capitalize on Expanded Global Footprint - - Brand Research & Development to Report Directly to CEO - - Enhanced Linkage between Global Operations, Generic R&D and Generic Commercial Markets - DUBLIN , Dec.
Sign-up for Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Allergan Acquisition investment picks
2015/1/12
Actavis plc (NYSE: ACT) and Allergan, Inc. (NYSE: AGN) today announced that the U.S. Federal Trade Commission (FTC) has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) with respect to Actavis’ pending acquisition of Allergan.
Sign-up for Actavis and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis’ Pending Acquisition of Allergan and Record Dates for Shareholder Meetings investment picks
2015/1/26
Actavis plc (NYSE: ACT) and Allergan, Inc. (NYSE: AGN) today announced that the U.S. Securities and Exchange Commission has declared effective Actavis’ registration statement on Form S-4 relating to Actavis’ pending acquisition of Allergan.
Sign-up for Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC investment picks
2015/1/26
- Meeting Dates for Actavis and Allergan Shareholder Meetings Set for March 10, 2015 - DUBLIN and IRVINE, Calif.
Sign-up for Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC investment picks
2015/1/22
The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been brought on behalf of those who sold the common stock of Allergan Inc. (“Allergan” or the “Company”) (NYSE:AGN) between February 25, 2014 and April 21, 2014, inclusive (the “Class Period”). If you sold Allergan common stock during the Class Period, you may move the Court for appointment as lead plaintiff by no later than February 17, 2015.
Sign-up for Lieff Cabraser Announces Class Action Litigation Against Allergan Inc. - AGN investment picks
2015/2/4
By Maria Armental Allergan Inc.'s fourth-quarter profit surged as the wrinkle-fighting Botox maker recorded double-digit sales growth across businesses.
Sign-up for Allergan Profit Surges On Higher Sales Ahead Of Actavis Takeover investment picks
2015/2/4
Allergan Inc. (AGN) said Wednesday that fourth-quarter net income was $537.2 million, or $1.77 a share, compared with $312.9 million, or $1.04 a share, for the same period a year ago.
Sign-up for Allergan's fourth quarter beats earnings forecasts investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

ETFS Holding Allergan, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: ETFS Holding Allegheny Technologies Inc  |  Next: ETFS Holding Allete, Inc.